{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:00:17Z","timestamp":1793660417203,"version":"4.5.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cutaneous T-cell lymphomas (CTCL) are characterized by focal infiltration of malignant T cell clones in solitary skin lesions. Many CTCL patients experience an indolent disease, but some progress to advanced disease with high fatality. We hypothesized that natural killer (NK) cells participate in local control of tumor growth in CTCL skin. Immunohistochemistry and flow cytometry analysis of the density, localization, phenotype and function of NK cells in twenty-nine fresh or formalin-fixed skin biopsies from twenty-four CTCL patients and twenty-three biopsies from twenty healthy controls highlighted higher numbers of CD56<jats:sup>+<\/jats:sup>CD3<jats:sup>-<\/jats:sup> NK cells in CTCL skin. A reduced fraction of CTCL skin NK cells expressed the maturation marker CD57, the cytotoxic protein granzyme B and the activation marker CD69, indicating reduced tumor-killing abilities of the NK cells. Retained expression of immune checkpoint proteins or inhibitory proteins including PD1, TIM3, LAG3, CD73 and NKG2A and the activating receptors CD16 and NKp46 indicated maintained effector functions. Indeed, the capacity of NK cells to produce anti-tumor acting IFN\u03b3 upon PMA+ionomycin stimulation was similar in cells from CTCL and healthy skin. Co-cultures of primary human NK cells or the NK cell line NKL with CTCL cells resulted in reduced levels of granzyme B and CD69, indicating that close cellular interactions with CTCL cells induced the impaired functional NK cell phenotype. In conclusion, increased numbers of NK cells in CTCL skin exhibit a partially impaired phenotype in terms of activity. Enhancing NK cell activity with NK cell activating cytokines such as IL-15 or immune checkpoint blockade therefore represents a potential immunotherapeutic approach in CTCL.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1168684","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T18:24:05Z","timestamp":1692987845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor"],"prefix":"10.3389","volume":"14","author":[{"given":"Andrea","family":"Scheffschick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Nenonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.","family":"Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Ehrstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wahren-Herlenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv","family":"Eidsmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2584","article-title":"Cutaneous lymphomas \u2014 an update","volume":"2019","author":"Kempf","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25577","article-title":"Mycosis fungoides and S\u00e9zary syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Hristov","year":"2019","journal-title":"Am J Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/sezary syndrome: validation of the revised international society for cutaneous lymphomas\/European organisation for research and treatment of cancer staging proposal","volume":"28","author":"Agar","year":"2021","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and sezary syndrome","volume":"139","author":"Kim","year":"2021","journal-title":"Arch Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2165\/00128071-200203030-00006","article-title":"Treatment of cutaneous T cell lymphoma current status and future directions","volume":"3","author":"Apisarnthanarax","year":"2002","journal-title":"J Clin Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer\u2013natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01205","article-title":"Cancer immunotherapy based on natural killer cells: Current progress and new opportunities","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00275","article-title":"Unleashing natural killer cells in the tumor microenvironment\u2013the next generation of immunotherapy","volume":"11","author":"Ben-Shmuel","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23914.x","article-title":"Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous Malignant cells in sezary syndrome patients","volume":"125","author":"Bouaziz","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1190","article-title":"Enhancement of the host immune responses in cutaneous T cell lymphoma by CpG oligodeoxynucleotides and IL-15","volume":"104","author":"Wysocka","year":"2004","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.23.4322","article-title":"CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, fas ligand, and killing inhibitory receptors and their relationship with clinical behavior","volume":"19","author":"Vermeer","year":"2001","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms24032743","article-title":"Natural killer T-like cells: immunobiology and role in disease","volume":"24","author":"Almeida","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048941","article-title":"Deep phenotypical characterization of human CD3+CD56+ T cells by mass cytometry","volume":"51","author":"Romero-Olmedo","year":"2021","journal-title":"Eur J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced Cutaneous T-Cell Lymphoma skin tumors","volume":"15","author":"Gaydosik","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Ca","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401778","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of plasmacytoid dendritic cell leukemia","volume":"14","author":"Drexler","year":"2000","journal-title":"Leukemia"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402610","article-title":"Bortezomib inhibits expression of TGF-\u03b21, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells","volume":"194","author":"Chang","year":"2015","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.coche.2017.11.006","article-title":"CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy","volume":"176","author":"Rosenberg","year":"2018","journal-title":"Physiol Behav"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100930","article-title":"NK cell infiltration is associated with improved overall survival in solid cancers: a systematic review and meta-analysis","volume":"14","author":"Nersesian","year":"2021","journal-title":"Transl Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4406","article-title":"Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis","volume":"67","author":"Wittnebel","year":"2007","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(01)00292-6","article-title":"Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer","volume":"35","author":"Villegas","year":"2002","journal-title":"Lung Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/cei.12392","article-title":"Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN) - \u03b3 by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells","volume":"2","author":"Hodge","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.lungcan.2012.01.017","article-title":"Lung Cancer Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: Mechanism for immune evasion","volume":"77","author":"Soriano","year":"2012","journal-title":"Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2020-000586","article-title":"Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer","volume":"8","author":"Hurkmans","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00422","article-title":"Functional significance of CD57 expression on human NK cells and relevance to disease","volume":"4","author":"Nielsen","year":"2013","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6248590","article-title":"Altered NKp30, NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is associated with tumor progression in human gastric cancer","volume":"2018","author":"Han","year":"2018","journal-title":"J Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1186\/ar4321","article-title":"CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence","volume":"15","author":"Krasselt","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/sj.leu.2403550","article-title":"Phenotype and function of a CD56+ peripheral blood monocyte","volume":"19","author":"Sconocchia","year":"2005","journal-title":"Leukemia"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00892","article-title":"CD56 in the immune system: More than a marker for cytotoxicity","volume":"8","author":"Van Acker","year":"2017","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2019.04.041","article-title":"Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity","volume":"177","author":"Gauthier","year":"2019","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2121-4","article-title":"An IL-15 superagonist\/IL-15R\u03b1 fusion complex protects and rescues NK cell-cytotoxic function from TGF-\u03b21-mediated immunosuppression","volume":"67","author":"Fujii","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00868","article-title":"IL-15 in the combination immunotherapy of cancer","volume":"11","author":"Waldmann","year":"2020","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.4331","article-title":"Homing and function of human skin \u03b3\u03b4 T cells and NK cells: relevance for tumor surveillance","volume":"176","author":"Ebert","year":"2006","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01242","article-title":"PD\/1-PD-Ls checkpoint: Insight on the potential role of NK cells","volume":"10","author":"Pesce","year":"2019","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01056","article-title":"Pembrolizumab in relapsed and refractory mycosis fungoides and S\u00e9zary syndrome: A multicenter phase II study","volume":"38","author":"Khodadoust","year":"2020","journal-title":"J Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI128895","article-title":"CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment","volume":"130","author":"Neo","year":"2020","journal-title":"J Clin Invest."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00924-14","article-title":"CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination","volume":"88","author":"Jost","year":"2014","journal-title":"J Virol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022842","article-title":"Human tumour immune evasion via TGF-\u03b2 blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity","volume":"6","author":"Wilson","year":"2011","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1168684\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T19:02:17Z","timestamp":1695409337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1168684\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2023.1168684"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1168684","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"article-number":"1168684"}}